Sotera Health (Nasdaq: SHC) announced a secondary offering of 31,838,253 common shares. All shares are being sold by affiliates of Warburg Pincus and GTCR; no other entities or individuals are selling. The Company is not issuing shares, receives no proceeds, but will pay offering expenses.
Loading...
Loading translation...
Positive
No new Sotera Health shares issued, avoiding direct equity dilution
Offering underwritten by Goldman Sachs & Co. LLC
Registration statement for the shares is already effective with the SEC
Negative
All 31,838,253 shares are being sold by existing major shareholders
Sotera Health will not receive any proceeds from the secondary offering
Company remains responsible for paying the expenses of the offering
News Market Reaction – SHC
+1.30%
1 alert
+1.30%Session close to close
$4.40BMarket Cap
0.1xRel. Volume
In the May 12 session, SHC gained 1.30%, reflecting a mild positive market reaction.
This announcement details another secondary offering in which affiliates of Warburg Pincus and GTCR ...
Analysis
This announcement details another secondary offering in which affiliates of Warburg Pincus and GTCR are selling 31,838,253 existing shares, while Sotera Health issues no new stock and receives no proceeds. Historically, similar offerings on 2024-09-04, 2025-11-06, and 2026-03-04 have prompted mixed price reactions. Investors may watch for continued sponsor sell-downs, leverage trends from recent 10-Q data, and any changes in insider activity as key indicators.
Key Figures
Secondary shares offered:31,838,253 sharesPar value per share:$0.01SEC filing date:February 27, 2024+1 more
4 metrics
Secondary shares offered31,838,253 sharesCommon stock in secondary offering by Warburg Pincus and GTCR affiliates
Par value per share$0.01Par value of SHC common stock in the offering
SEC filing dateFebruary 27, 2024Registration statement for the offered securities
Prospectus phone1-866-471-2526Goldman Sachs prospectus department contact for this offering
25M-share sponsor sale; offering shifted sponsor control but stock rose.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent secondary offerings by selling sponsors have usually coincided with negative one-day moves, though one event saw a strong gain.
Recent Company History
Over the past two years, SHC has seen multiple secondary offerings where affiliates of Warburg Pincus and GTCR sold large share blocks while the company received no proceeds and covered offering expenses. Prior offerings on Sep 4, 2024, Nov 6, 2025, and Mar 4, 2026 all followed this pattern. Price reactions were generally negative, except the Sep 2024 deal, highlighting mixed market responses to recurring sponsor sell-downs.
"today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares"
A secondary offering is when a company sells new shares of its stock to the public after its initial sale. This allows existing shareholders or the company itself to raise additional money. For investors, it can impact the stock’s price by increasing the total number of shares available, which may influence the stock’s value and how the market perceives the company’s financial health.
"Goldman Sachs & Co. LLC is acting as the underwriter for the Offering."
An underwriter is a financial firm that evaluates, guarantees and helps sell a new security offering—such as a stock or bond—by buying the issue from the issuer and reselling it to investors or organizing the sale. Think of them as a bridge or safety net: they take on the risk, set the price, handle marketing and paperwork, and their work determines how much money a company can raise and how smoothly the offering reaches the market.
"The Offering is being made only by means of a prospectus."
A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.
registration statementregulatory
"A registration statement relating to these securities was filed with the Securities"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement.
Goldman Sachs & Co. LLC is acting as the underwriter for the Offering.
The Offering is being made only by means of a prospectus. Copies of the preliminary prospectus relating to the Offering may be obtained, when available, from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526 or by email at Prospectus-ny@ny.email.gs.com.
A registration statement relating to these securities was filed with the Securities and Exchange Commission on February 27, 2024, and became effective automatically.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-looking Statements:
Statements in this press release regarding the Company that are not historical facts are “forward-looking statements” that involve risks and uncertainties. Certain of these risks and uncertainties are described in the Company’s registration statement on Form S-3 filed with the SEC, including under the headings “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements,” under the headings “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Company’s most recent Annual Report on Form 10-K. Forward-looking statements made in this release speak only as of the date of this release, and the Company undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances, except as required by law.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
INVESTOR RELATIONS CONTACT:
Jason Peterson Vice President, Investor Relations, Sotera Health IR@soterahealth.com
What did Sotera Health (SHC) announce on May 11, 2026 about a secondary offering?
Sotera Health announced a secondary offering of 31,838,253 common shares sold by existing shareholders. According to Sotera Health, the Company is not issuing new shares and will not receive any proceeds from this underwritten secondary sale.
How many Sotera Health (SHC) shares are included in the May 2026 secondary offering?
The secondary offering includes 31,838,253 shares of Sotera Health common stock. According to Sotera Health, all 31,838,253 shares are being sold by affiliates of Warburg Pincus and GTCR, with no other entities or individuals participating as selling stockholders.
Who is selling Sotera Health (SHC) shares in the May 2026 secondary offering?
Only affiliates of Warburg Pincus and GTCR are selling shares in the offering. According to Sotera Health, no other entities or individuals are selling stock, and the Company itself is not offering any shares in this secondary transaction.
Does Sotera Health (SHC) receive any proceeds from the May 2026 secondary offering?
Sotera Health will not receive any proceeds from this secondary offering. According to Sotera Health, all sale proceeds go to the selling stockholders, while the Company will pay the offering expenses under its Amended and Restated Registration Rights Agreement.
Who is the underwriter for the Sotera Health (SHC) May 2026 secondary stock offering?
Goldman Sachs & Co. LLC is acting as the underwriter for the offering. According to Sotera Health, the secondary sale of 31,838,253 shares will be made only by means of a prospectus available through Goldman Sachs’ prospectus department.
What is the SEC registration status of the Sotera Health (SHC) secondary offering shares?
The shares in the secondary offering are covered by an effective SEC registration statement. According to Sotera Health, a registration statement for these securities was filed on February 27, 2024 and became automatically effective before the May 2026 launch.
